Omega Therapeutics, Inc.

Omega Therapeutics, Inc.

OMGA
Omega Therapeutics, Inc.US flagNASDAQ Global Select
0.14
USD
- -
- -
7.90MMarket Cap

Income Statement (USD)

APIChatGPT
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
As of date
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
Sales/Revenue/Turnover
- -
- -
- -
2
3
+ Sales & Services Revenue
- -
- -
- -
2
3
- Cost of Revenue
- -
- -
- -
- -
- -
+ Cost of Goods & Services
- -
- -
- -
- -
- -
Gross Profit
- -
- -
- -
- -
- -
+ Other Operating Income
- -
- -
- -
-2
-3
- Operating Expenses
17
29
66
105
103
+ Selling, General & Admin
4
6
17
24
26
+ Research & Development
12
21
48
81
77
+ Other Operating Expense
1
1
2
- -
- -
Operating Income (Loss)
-17
-29
-66
-103
-100
- Non-Operating (Income) Loss
1
1
2
- -
-3
+ Interest Expense, Net
1
1
1
- -
-3
+ Interest Expense
1
1
1
- -
- -
- Interest Income
- -
- -
- -
- -
3
+ Other Non-Op (Income) Loss
- -
- -
1
- -
- -
Pretax Income
-18
-29
-68
-103
-97
- Income Tax Expense (Benefit)
- -
- -
- -
- -
- -
- (Income) Loss from Affiliates
- -
- -
- -
- -
- -
Income (Loss) from Cont Ops
-18
-29
-68
-103
-97
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
- -
Income (Loss) Incl. MI
-18
-29
-68
-103
-97
- Minority Interest
- -
- -
- -
- -
- -
Net Income, GAAP
-18
-29
-68
-103
-97
- Preferred Dividends
- -
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
- -
Net Income Avail to Common, GAAP
-18
-29
-68
-103
-97
EBIT
-17
-29
-66
-103
-100
EBITDA
-17
-27
-65
-98
-93
EBITDA Margin (%)
- -
- -
-44,892.36
-4,706.99
-3,021.65
EBITA
-17
-29
-66
-103
-100
Gross Margin (%)
- -
- -
100
100
100
Operating Margin (%)
- -
- -
-45,855.56
-4,957.36
-3,240.5
Profit Margin (%)
- -
- -
-47,416.67
-4,954.22
-3,148.93
Sales per Employee
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
Depreciation Expense
1
1
1
5
7
Basic Weighted Avg Shares
26
31
22
48
54
Basic EPS, GAAP
-0.69
-0.95
-3.05
-2.14
-1.8
Basic EPS from Cont Ops
-0.69
-0.95
-3.05
-2.14
-1.8
Diluted Weighted Avg Shares
26
31
22
48
54
Diluted EPS, GAAP
-0.69
-0.95
-3.05
-2.14
-1.8
Diluted EPS from Cont Ops
-0.69
-0.95
-3.05
-2.14
-1.8

Balance Sheet (USD)

APIChatGPT
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
As of date
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
Total Current Assets
3
24
229
138
90
+ Cash, Cash Equivalents & STI
2
23
225
125
73
+ Cash & Cash Equivalents
2
23
186
71
68
+ ST Investments
- -
- -
39
54
5
+ Accounts & Notes Receiv
- -
- -
1
2
7
+ Accounts Receivable, Net
- -
- -
- -
- -
5
+ Notes Receivable, Net
- -
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
- -
+ Other Receivable, Net
- -
- -
- -
2
2
+ Inventories
- -
- -
- -
- -
- -
+ Raw Materials
- -
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
- -
+ Finished Goods
- -
- -
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
- -
+ Other ST Assets
- -
1
3
11
9
+ Misc ST Assets
- -
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
- -
Total Noncurrent Assets
3
4
4
8
114
+ Property, Plant & Equip, Net
3
3
4
8
114
+ Property, Plant & Equip
4
6
7
13
120
- Accumulated Depreciation
1
2
4
5
6
+ LT Investments & Receivables
- -
- -
- -
- -
- -
+ LT Investments
- -
- -
- -
- -
- -
+ LT Receivables
- -
- -
- -
- -
- -
+ Other LT Assets
1
1
- -
1
- -
+ Total Intangible Assets
- -
- -
- -
- -
- -
+ Goodwill
- -
- -
- -
- -
- -
+ Other Intangible Assets
- -
- -
- -
- -
- -
+ LT Deferred Tax Assets
- -
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
- -
+ Misc LT Assets
1
1
- -
1
- -
Total Assets
6
28
233
146
204
+ Payables & Accruals
1
3
9
13
5
+ Accounts Payable
1
1
2
3
2
+ Accrued Taxes
- -
- -
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
- -
+ Other Payables & Accruals
- -
2
7
9
3
+ ST Debt
- -
3
- -
5
15
+ ST Borrowings
- -
3
- -
3
4
+ ST Finance Leases
- -
- -
- -
2
11
+ Other ST Liabilities
1
1
3
5
6
+ Deferred Revenue
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
+ Misc ST Liabilities
1
1
3
5
6
Total Current Liabilities
2
8
12
22
27
+ LT Debt
12
9
20
18
113
+ LT Borrowings
12
9
20
17
15
+ LT Finance Leases
- -
- -
- -
1
98
+ Other LT Liabilities
28
76
1
- -
6
+ Accrued Liabilities
- -
- -
- -
- -
- -
+ Pension Liabilities
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
+ Misc LT Liabilities
28
76
1
- -
6
Total Noncurrent Liabilities
40
85
21
18
120
Total Liabilities
42
93
33
40
146
+ Preferred Equity and Hybrid Capital
- -
- -
- -
- -
- -
+ Share Capital & APIC
1
2
335
344
393
+ Common Stock
- -
- -
- -
- -
- -
+ Additional Paid in Capital
1
2
335
344
393
- Treasury Stock
- -
- -
- -
- -
- -
+ Retained Earnings
-37
-66
-135
-237
-335
+ Other Equity
- -
- -
- -
- -
- -
Equity Before Minority Interest
-36
-65
201
106
58
+ Minority/Non Controlling Interest
- -
- -
- -
- -
- -
Total Equity
-36
-65
201
106
58
Total Liabilities & Equity
6
28
233
146
204
Shares Outstanding
47
47
48
48
55
Number of Employees
- -
- -
- -
- -
- -
Capital Leases - Total
- -
- -
- -
3
110
Net Debt
10
-11
-167
-51
-50
Net Debt to Equity
-26.78
17.36
-83.05
-47.82
-85.42
Tangible Common Equity Ratio
-586.91
-230.13
85.98
72.58
28.39
Current Ratio
1.19
3.12
19.13
6.26
3.35
Cash Conversion Cycle
- -
- -
- -
- -
- -

Cash Flow Statement (USD)

APIChatGPT
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
As of date
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
+ Net Income
-18
-29
-68
-103
-97
+ Depreciation & Amortization
1
1
1
5
7
+ Non-Cash Items
- -
1
5
9
9
+ Stock-Based Compensation
- -
1
3
8
9
+ Deferred Income Taxes
- -
- -
- -
- -
- -
+ Asset Impairment Charge
- -
- -
- -
- -
- -
+ Other Non-Cash Adj
- -
- -
1
1
- -
+ Chg in Non-Cash Work Cap
1
2
5
-10
-9
+ (Inc) Dec in Accts Receiv
- -
- -
- -
- -
-6
+ (Inc) Dec in Inventories
- -
- -
- -
- -
- -
+ (Inc) Dec in Prepaid Assets
- -
-1
-3
-9
1
+ Inc (Dec) in Accts Payable
1
2
7
4
-7
+ Inc (Dec) in Other
- -
- -
- -
-5
2
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
Cash from Operating Activities
-16
-26
-58
-99
-92
+ Change in Fixed & Intang
- -
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
1
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
1
+ Disp of Intangible Assets
- -
- -
- -
- -
- -
+ Acq of Fixed & Intang
-1
-2
-1
-1
-3
+ Acq of Fixed Prod Assets
-1
-2
-1
-1
-3
+ Acq of Intangible Assets
- -
- -
- -
- -
- -
+ Cash (Repurchase) of Equity
- -
- -
131
- -
40
+ Increase in Capital Stock
- -
- -
131
- -
40
+ Decrease in Capital Stock
- -
- -
- -
- -
- -
+ Net Change in LT Investment
- -
- -
-39
-17
50
+ Dec in LT Investment
- -
- -
- -
41
70
+ Inc in LT Investment
- -
- -
-39
-57
-20
+ Net Cash From Acq & Div
- -
- -
- -
- -
- -
+ Cash from Divestitures
- -
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
- -
+ Cash for JVs
- -
- -
- -
- -
- -
+ Other Investing Activities
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
Cash from Investing Activities
-1
-2
-40
-18
48
+ Dividends Paid
- -
- -
- -
- -
- -
+ Net Cash From Debt
4
- -
8
- -
2
+ Cash From Debt
4
- -
8
- -
3
+ Repayments of Debt
- -
- -
- -
- -
-1
+ Other Financing Activities
8
49
122
1
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
Cash from Financing Activities
12
49
262
1
42
Effect of Foreign Exchange Rates
- -
- -
- -
- -
- -
Net Changes in Cash
-5
21
164
-116
-2
EBITDA
-17
-27
-65
-98
-93
EBITDA Margin (%)
- -
- -
-44,892.36
-4,706.99
-3,021.65
Free Cash Flow
-17
-28
-59
-100
-94
Net Cash Paid for Acquisitions
- -
- -
- -
- -
- -
Free Cash Flow to Firm
- -
- -
- -
- -
- -
Free Cash Flow to Equity
- -
-28
-51
-100
-92
Free Cash Flow per Basic Share
-0.64
-0.9
-2.64
-2.09
-1.75
Price/Free Cash Flow
- -
- -
-4.52
-2.81
-1.83
Cash Flow to Net Income
0.87
0.89
0.84
0.96
0.94
Capital Expenditures
-1
-2
-1
-1
-3